World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-EON-17010697
Date of registration: 2017-02-21
Prospective Registration: Yes
Primary sponsor: Guangzhou University of Chinese Medicine
Public title: Protocol of the Project of Malaria Elimination in the Plateaux Region of the Togolese Republic (Sino-Togolese Cooperation)
Scientific title: Protocol of the Project of Malaria Elimination in the Plateaux Region of the Togolese Republic (Sino-Togolese Cooperation)
Date of first enrolment: 2017-03-01
Target sample size: Control area:125611;Demonstration area:125611;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=18192
Study type:  Epidemilogical research
Study design:  Non randomized control  
Phase:  Other
Countries of recruitment
Contacts
Name: Jianping Song   
Address:  436 Chentaigong Road, Yongxing Village, Baiyun district, Guangzhou, Guangdong, China
Telephone: +86 020-87473318
Email: songjpgz@sina.com
Affiliation:  Guangzhou university of Chinese Medicine
Name: Yingying Lai   
Address:  436 Chentaigong Road, Yongxing Village, Baiyun district, Guangzhou, Guangdong, China
Telephone: +86 18814099608
Email: 609621147@qq.com
Affiliation:  Guangzhou university of Chinese Medicine
Key inclusion & exclusion criteria
Inclusion criteria: Residents and immigrations over 6 years old in Est-Mono district during the mass drug administration.
Exclusion criteria: 1. The people who are extremely sensitive to the drug or one of the ingredients
2. Pregnant women in the first three months of pregnancy;
3. The children who are under 6 months or younger;
4. The patients who have serious illness requiring hospitalization.


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Malaria
Intervention(s)
Control area:Curent antimalaria measures in Togo;Demonstration area:Mass Drug Administration with Artemisinin-Piperaquine;
Primary Outcome(s)
Diagnosed malaria cases per month by health care;Infection rate among people;Mass drug administration coverage;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Guangdong New South Group Co., Ltd.
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history